Isolation of antimicrobial resistant bacteria in upper respiratory tract infections of patients

被引:0
|
作者
Li-min Wang
Xiao-liang Qiao
Liang Ai
Jing-jing Zhai
Xue-xia Wang
机构
[1] Women and Infants Hospital of Zhengzhou,Department of Clinical Laboratory
来源
3 Biotech | 2016年 / 6卷
关键词
Isolation; Antibiotic resistance; Upper respiratory tract infection; Biofilm;
D O I
暂无
中图分类号
学科分类号
摘要
Haemophilus influenzae, Streptococcus pyogenes, Moraxella catarrhalis, Staphylococcus aureus, and Streptococcus pneumoniae are usual cause of upper respiratory tract infection cases. The present study aims the isolation of bacterial strains which are resistant to the commonly prescribed antibiotics. In total, 900 throat swabs were obtained from the patients suffering from upper respiratory tract infections residing in three different localities. The maximum number of isolates (64 %) were obtained from locality-1 (L-1), whereas lowest isolates were found in second locality (L-2). H. influenzae was found to be the most dominant bacterial pathogen in upper respiratory tract infections in patients with 42 % of the total isolates. H. influenzae and Chlamydia pneumoniae were resistant to β-lactam antibiotics but susceptible to fluroquinolones and aminoglycosides, whereas S. aureus and S. pneumoniae were found to be highly resistant to β-lactam, aminoglycosides and fluroquinolones. S. aureus was also moderately resistant to fluroquinolones and aminoglycosides with percent resistance of 26, 33 and 18 %, respectively. 56 % S. pneumoniae isolates were resistant against erythromycin, 27 % against chloramphenicol and 23 % against cefuroxime. The studies revealed that S. aureus and S. pneumoniae strains were high producer of biofilms which could be one of the reasons for their high pathogenicity.
引用
收藏
相关论文
共 50 条
  • [31] PATHOGENICITY AND THERAPY OF ANAEROBIC-BACTERIA IN UPPER RESPIRATORY-TRACT INFECTIONS
    BROOK, I
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1987, 6 (01) : 131 - 136
  • [32] Isolation, identification and characterization of influenza viruses from upper respiratory tract infections
    Khan, AA
    Zaidi, SSZ
    Hameed, A
    Asghar, H
    Hasan, M
    Sharif, S
    Fazli, Z
    Dil, AS
    JOURNAL OF CLINICAL VIROLOGY, 2003, 28 : S103 - S104
  • [33] INCIDENCE OF UPPER RESPIRATORY-TRACT INFECTIONS IN SPLENECTOMIZED PATIENTS
    GORDON, DM
    CROSS, AS
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (02): : 279 - 279
  • [34] Effects of upper respiratory tract infections in patients with cystic fibrosis
    Collinson, J
    Nicholson, KG
    Cancio, E
    Ashman, J
    Ireland, DC
    Hammersley, V
    Kent, J
    OCallaghan, C
    THORAX, 1996, 51 (11) : 1115 - 1122
  • [35] Safety and efficacy of roxithromycin in patients with upper respiratory tract infections
    Barreto, DG
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1996, 57 : 79 - 86
  • [36] Upper respiratory tract infections in athletes
    Page, Clifton L.
    Diehl, Jason J.
    CLINICS IN SPORTS MEDICINE, 2007, 26 (03) : 345 - +
  • [37] Biofilms and infections of the upper respiratory tract
    Pintucci, J. P.
    Corno, S.
    Garotta, M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2010, 14 (08) : 683 - 690
  • [38] UPPER RESPIRATORY TRACT INFECTIONS IN CHILDREN
    DERY, P
    VIE MEDICALE AU CANADA FRANCAIS, 1974, 3 (12): : 1202 - 1203
  • [39] Upper respiratory tract infections -: Introduction
    Passali, D.
    JOURNAL OF CHEMOTHERAPY, 2006, 18 : 53 - +
  • [40] Prevention of Infections of the Upper Respiratory Tract
    Voss, Sebastian
    Schnakenberg, Rieke
    Weckbecker, Klaus
    Bleckwenn, Markus
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2017, 142 (03) : 217 - 224